UA112448C2 - COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE - Google Patents
COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASEInfo
- Publication number
- UA112448C2 UA112448C2 UAA201404226A UAA201404226A UA112448C2 UA 112448 C2 UA112448 C2 UA 112448C2 UA A201404226 A UAA201404226 A UA A201404226A UA A201404226 A UAA201404226 A UA A201404226A UA 112448 C2 UA112448 C2 UA 112448C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- auto
- composition
- immune disease
- immune
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- ZWBTYMGEBZUQTK-PVLSIAFMSA-N [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate Chemical compound CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4NC5(CCN(CC(C)C)CC5)N=c4c(=NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C ZWBTYMGEBZUQTK-PVLSIAFMSA-N 0.000 abstract 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 abstract 1
- 229960002626 clarithromycin Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 229960000885 rifabutin Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Винахід стосується застосування композиції, що містить кларитроміцин, рифабутин і клофазамін, для виготовлення лікарського засобу для лікування розсіяного склерозу.The invention relates to the use of a composition containing clarithromycin, rifabutin and clofazamine for the manufacture of a medicament for the treatment of multiple sclerosis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161536824P | 2011-09-20 | 2011-09-20 | |
| PCT/IB2012/002252 WO2013041963A2 (en) | 2011-09-20 | 2012-09-19 | A composition and method for treating an autoimmune disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA112448C2 true UA112448C2 (en) | 2016-09-12 |
Family
ID=56921087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201404226A UA112448C2 (en) | 2011-09-20 | 2012-09-19 | COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA112448C2 (en) |
-
2012
- 2012-09-19 UA UAA201404226A patent/UA112448C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201118656D0 (en) | New compounds | |
| UA116999C2 (en) | SELECTED HEMAGLUTIN ANTIBODY AND PHARMACEUTICAL COMPOSITION TO BE CONTAINED | |
| MX373763B (en) | USE OF A SUSTAINED-RELEASE COMBINATION COMPOSITION OF ACAMPROSATE AND BACLOFEN FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS. | |
| MX349004B (en) | New compounds. | |
| EA201200551A1 (en) | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSED FORM, METHODS OF THEIR PRODUCTION AND APPLICATION FOR TREATMENT | |
| UA117098C2 (en) | A COMPOUND CONTAINING MODIFIED OLIGONUCLEOTIDE | |
| MX366899B (en) | New compounds. | |
| DOP2016000253A (en) | NEW COMPOUNDS | |
| EA201591687A1 (en) | INDUCTION THERAPY RITUXIMAB WITH SUBSEQUENT TREATMENT USING ACCETATE GLATIRAMER | |
| MX356728B (en) | Pharmaceutical combination for use in the treatment of diabetes type 2. | |
| EA201690039A1 (en) | RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION | |
| GEP201706621B (en) | Benzamides | |
| EA201590359A1 (en) | TREATMENT OF RHEUMATOID ARTHRITIS | |
| UA116889C2 (en) | COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS | |
| BR112015031417A8 (en) | pharmaceutical dosage form, pharmaceutical composition, methods for treating a patient in need of cysteamine and for preparing a dosage form | |
| MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
| NI201600070A (en) | AUTOTAXIN TETRAYCLIC INHIBITORS | |
| EA201591507A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM | |
| EA201400623A1 (en) | NEW 2H-INDASOLS AS ANTAGONISTS EP EPCEPTOR | |
| BR112013026680A2 (en) | compound, method of treating an inflammatory disease and pharmaceutical composition | |
| EA201390616A1 (en) | TREATMENT OF VIOLATIONS ASSOCIATED WITH THE MECP2 GENE | |
| MX367926B (en) | Pharmaceutical composition for a sustained release of lanreotide. | |
| EA201491581A1 (en) | ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ | |
| IN2014DN03010A (en) | ||
| EA201400444A1 (en) | DERIVATIVES 2-OXOPYPERIDINYL |